Physician

Ranju Chandrashekariah, M.D.

According to 2025 Medicare claims, Ranju Chandrashekariah, M.D. (NPI: 1851354385) practices critical care (intensivists) in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is TUSCALOOSA LUNG & SLEEP CONSULTANTS, PC (NPI: 1447215561; TIN: 63-0778894) and primary practice location at 35401-2029.

Chandrashekariah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 750 traditional Medicare patients, billed 5,364 HCPCS/CPT codes, and received $387,006 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 4,528 prescription claims across 634 beneficiaries totaling $1,696,100 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,050 claims. Open Payments data shows 126 records totaling $2,190. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $442,396 to $387,006. In contrast, Part D prescription costs have moved sharply higher in recent years, from $161,377 to $1,696,100. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	829	5,777	$442,396
2016	987	6,771	$534,162
2017	976	7,612	$575,993
2018	858	6,336	$466,078
2019	891	6,808	$509,890
2020	971	6,675	$552,183
2021	916	5,792	$456,379
2022	759	4,956	$363,615
2023	722	4,794	$360,448
2024	750	5,364	$387,006

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	749	$161,377
2016	171	750	$157,153
2017	230	1,158	$248,239
2018	293	1,576	$347,195
2019	344	2,163	$688,526
2020	447	2,874	$951,585
2021	489	3,430	$1,089,511
2022	515	3,636	$1,737,099
2023	569	4,208	$2,019,613
2024	634	4,528	$1,696,100

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,023	2,992	$247,495
2016	1,215	3,150	$200,142
2017	1,168	2,794	$119,588
2018	1,088	2,632	$119,745
2019	1,125	2,631	$133,852
2020	1,234	2,910	$159,514
2021	1,099	2,802	$149,193
2022	1,210	2,630	$154,848
2023	1,268	3,057	$179,960
2024	1,252	3,050	$179,244

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	346	1,355	$83
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	371	725	$83
94729	Test to examine how well the lungs exchange gases	213	221	$36
94060	Test to measure expiratory airflow and volume changes before and after medication administration	259	471	$25
88738	Hemoglobin measurement	195	202	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	1,164	40,798	$857,927
Tezspire	Tezepelumab-Ekko	58	1,624	$234,417
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	235	8,818	$182,453
Breo Ellipta	Fluticasone/Vilanterol	226	7,860	$101,704
Dupixent Pen	Dupilumab	13	364	$49,670

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	37	$28,565
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	50	333	$25,020
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	19	$17,343
A7030	Full face mask used with positive airway pressure device, each	N	106	192	$16,308
A7031	Face mask interface, replacement for full face mask, each	N	87	174	$15,818

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	126	$2,190	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ranju Chandrashekariah, M.D.?

Tedicare shows public-source Medicare data for Ranju Chandrashekariah, M.D. (NPI 1851354385), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ranju Chandrashekariah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ranju Chandrashekariah, M.D.?

Ranju Chandrashekariah, M.D. is linked to TUSCALOOSA LUNG & SLEEP CONSULTANTS, PC (billing NPI 1447215561) in the available physician profile data.

Does Ranju Chandrashekariah, M.D. have Open Payments data?

Ranju Chandrashekariah, M.D. has 126 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.